Medical Research News and Research

RSS

Sen. Lugar highlights potential bioterrorism threat posed by unsecured medical facilities in East Africa

Senator Dick Lugar on Friday said that poorly secured medical laboratories in East African countries, which host insurgent groups linked to Al Qaeda, are vulnerable to bioterrorism, Agence France-Presse reports.

16 Nov 2010

High-dose prescription omega-3 does not reduce recurrence of atrial fibrillation

Although some data have suggested that omega-3 fatty acid supplements, such as from fish oil, may improve treatment of atrial fibrillation, a randomized trial with more than 600 patients finds that treatment with high-dose prescription omega-3 did not reduce the recurrence of atrial fibrillation over six months, according to a study that will appear in the December 1 issue of JAMA. The study is being released early online because it will be presented at the American Heart Association's annual meeting.

15 Nov 2010

Dialysis patients at elevated risk for sudden cardiac death: Study

Approximately 500,000 Americans require dialysis to treat kidney disease; of that population nearly half of the deaths that occur are caused by cardiovascular disease. Dialysis patients are at elevated risk for sudden cardiac death, but physicians are unclear why these deaths occur because little research has been done to examine how to best manage heart disease in this high-risk population.

15 Nov 2010

IBM enters agreement with Central Norway Regional Health Authority to support healthcare system

At the Smarter Industries Symposium today in Barcelona, IBM announced it has entered into an agreement with Central Norway Regional Health Authority to provide information technology to support all hospitals in Norway and improve coordination and reporting of health information, logistics and finance. The agreement is estimated at $120 million USD.

12 Nov 2010

Discovery on immune system paves way to new vaccine against pneumococcal disease

A new breakthrough in the fight against pneumonia, meningitis and septicaemia has been announced today by scientists in Leicester and Dublin. The discovery will lead to a dramatic shift in our understanding of how the body's immune system responds to infection caused by Streptococcus pneumoniae and pave the way for more effective vaccines.

12 Nov 2010

GPI launches new advocacy coalition to advance embryonic stem cell research in U.S.

The Genetics Policy Institute (GPI) today announced the launch of a new advocacy coalition of 30 organizations to foster public awareness and advance the cause of embryonic stem cell research in the United States.

12 Nov 2010

Roche, CapitalBio to initiate strategic partnership for molecular diagnostic applications

Roche Diagnostics and CapitalBio have announced their intention to initiate a strategic partnership targeting molecular diagnostic applications and the development of technologies to fill the unmet needs of researchers worldwide. This new development builds on the genomics and diagnostics expertise of the two companies and will focus on furthering microarray technologies and complementary products for molecular diagnostic applications.

From Roche Sequencing and Life Science 11 Nov 2010

New insect control method can bring decline in malaria-bearing mosquitoes

Research carried out in Mali, West Africa, has demonstrated that a new, safe and uncomplicated insect control method, developed at the Hebrew University of Jerusalem, can bring about a serious decline in malaria-bearing mosquitoes in afflicted regions in the world.

11 Nov 2010

FSU and Denver VA Medical Center awarded $17M grant to establish Military Suicide Research Consortium

American soldiers are taking their own lives in the largest numbers since the military began keeping records, and the Department of Defense has enlisted the help of The Florida State University in waging the war against suicide.

11 Nov 2010

Statins benefit ‘at risk’ patients but are underused: Study

A look at some of the large clinical trials and studies has shown that thousands of deaths could be prevented a year if people at risk of heart attack or stroke are prescribed high doses of statins. The review involves data from 170,000 patients in 26 randomized trials. The paper is published in the journal The Lancet.

10 Nov 2010

REF donates $24 million in innovative RA research

The American College of Rheumatology Research and Education Foundation today announced it has raised nearly $28 million, and funded $24 million, in RA research through its Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign - putting the Foundation two million from its initial $30 million goal.

9 Nov 2010

Innovative method for in-cell gene manipulation

A cross-disciplinary Small Medicine and Advanced Research Translation (SMART) team led by Prof. Dar-Bin Shieh of Institute of Oral Medicine in Medical College at National Cheng Kung University (NCKU), Tainan, Taiwan, has announced a breakthrough in the precision in-cell gene scission at pre-designed sequence sites using Artificial Targeting Light Activated Nano Scissors (ATLANS) and a custom build photonic device.

9 Nov 2010

Research demonstrates a safe method to control malaria in Africa

9 Nov 2010

DHA protects brain tissue and promotes recovery in acute ischemic stroke

Research led by Dr. Nicolas Bazan, Boyd Professor, Villere Chair, and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center, has shown that Docosahexaenoic acid (DHA), a component of fish oil, is a powerful therapeutic agent that can protect brain tissue and promote recovery in an experimental model of acute ischemic stroke, even when treatment is delayed by up to five hours.

9 Nov 2010

Study explains link between morbid obesity and metabolic syndrome

Scientists have found that the fat cells and tissues of morbidly obese people and animals can reach a limit in their ability to store fat appropriately. Beyond this limit several biological processes conspire to prevent further expansion of fat tissue and in the process may trigger other health problems.

9 Nov 2010

Study discovers role of Vav1 oncogene in several cancers

Researchers at the Hebrew University of Jerusalem have discovered that Vav1 - an oncogene (cancer-causing gene) found in recent years to be one of the factors in tumorous tissue growth -- plays a wider role in several types of cancer than had previously been thought. The discovery has implications for further concentration on targeting this gene in cancer research.

9 Nov 2010

$Beta blockers for high blood pressure also reduce fracture risk: Study$

Beta blockers for high blood pressure also reduce fracture risk: Study

Beta blockers, one of the most commonly used types of cardiovascular drugs, taken by about 20 per cent of the population, have been found to cut a person's incidence of bone fracture by half. This new and welcome side effect was reported by Professor Tuan Nguyen from Sydney's Garvan Institute of Medical Research and his Australian-based colleagues. “Indeed, we found that men and women who used beta-blockers had a 50 per cent lower risk of fracture than those not using beta blockers… We were very excited about the finding because, as you know, a lot of elderly people use beta blockers ... it’s a very significant public health issue,” he said.

8 Nov 2010

Manhattan awarded $244,279 grant under QTDP program

Manhattan Pharmaceuticals, Inc. announced today that it has been awarded $244,279 in funding under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) credit program. The Company has received this funding for its lead product candidate AST-726 for the treatment of vitamin B12 deficiency.

8 Nov 2010

Laparoscopic surgery safe and effective for removing bowel tumours

Laparoscopic or 'keyhole' surgery is a safe, effective way of removing bowel tumours and should be offered to all patients undergoing surgery for colorectal cancer, according to researchers from the University of Leeds.

8 Nov 2010

Radiotherapy can benefit men with high risk prostate cancer: Research

Men treated with radiotherapy as well as hormone therapy for advanced prostate cancer were 43 per cent less likely to die from the disease, according to trial results presented at the NCRI Cancer Conference in Liverpool today (Monday).

8 Nov 2010

Medical Research News and Research

Sen. Lugar highlights potential bioterrorism threat posed by unsecured medical facilities in East Africa

High-dose prescription omega-3 does not reduce recurrence of atrial fibrillation

Dialysis patients at elevated risk for sudden cardiac death: Study

IBM enters agreement with Central Norway Regional Health Authority to support healthcare system

Discovery on immune system paves way to new vaccine against pneumococcal disease

GPI launches new advocacy coalition to advance embryonic stem cell research in U.S.

Roche, CapitalBio to initiate strategic partnership for molecular diagnostic applications

New insect control method can bring decline in malaria-bearing mosquitoes

FSU and Denver VA Medical Center awarded $17M grant to establish Military Suicide Research Consortium

Statins benefit ‘at risk’ patients but are underused: Study

REF donates $24 million in innovative RA research

Innovative method for in-cell gene manipulation

Research demonstrates a safe method to control malaria in Africa

DHA protects brain tissue and promotes recovery in acute ischemic stroke

Study explains link between morbid obesity and metabolic syndrome

Study discovers role of Vav1 oncogene in several cancers

Beta blockers for high blood pressure also reduce fracture risk: Study

Manhattan awarded $244,279 grant under QTDP program

Laparoscopic surgery safe and effective for removing bowel tumours

Radiotherapy can benefit men with high risk prostate cancer: Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News